353 related articles for article (PubMed ID: 22266336)
1. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion.
Kim SW; Jin Y; Shin JH; Kim ID; Lee HK; Park S; Han PL; Lee JK
Neurobiol Dis; 2012 Apr; 46(1):147-56. PubMed ID: 22266336
[TBL] [Abstract][Full Text] [Related]
2. Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain.
Shin JH; Lee HK; Lee HB; Jin Y; Lee JK
Neurosci Lett; 2014 Jan; 558():159-63. PubMed ID: 24246904
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain.
Kim ID; Shin JH; Lee HK; Jin YC; Lee JK
Neurosci Lett; 2012 Sep; 525(2):179-83. PubMed ID: 22877697
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect.
Lim CM; Kim SW; Park JY; Kim C; Yoon SH; Lee JK
J Neurosci Res; 2009 Mar; 87(4):1037-45. PubMed ID: 18855941
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of OBA-09, a salicylic acid/pyruvate ester, in the postischemic brain.
Lee HK; Kim SW; Jin Y; Kim ID; Park JY; Yoon SH; Lee JK
Brain Res; 2013 Aug; 1528():68-79. PubMed ID: 23850644
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats.
Gong G; Xiang L; Yuan L; Hu L; Wu W; Cai L; Yin L; Dong H
PLoS One; 2014; 9(3):e89450. PubMed ID: 24594628
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway.
Zhang J; Wu Y; Weng Z; Zhou T; Feng T; Lin Y
Brain Res; 2014 Sep; 1582():176-86. PubMed ID: 25111887
[TBL] [Abstract][Full Text] [Related]
8. HMGB1-binding heptamer suppresses the synergistic effect of HMGB1 and LPS by interacting directly with HMGB1.
Kim ID; Luo L; Lee HB; Lee HK; Lee JK
Neurosci Lett; 2015 Apr; 593():40-4. PubMed ID: 25769801
[TBL] [Abstract][Full Text] [Related]
9. Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain.
Kim JB; Lim CM; Yu YM; Lee JK
J Neurosci Res; 2008 Apr; 86(5):1125-31. PubMed ID: 17975839
[TBL] [Abstract][Full Text] [Related]
10. The effect of biodegradable gelatin microspheres on the neuroprotective effects of high mobility group box 1 A box in the postischemic brain.
Jin YC; Kim SW; Cheng F; Shin JH; Park JK; Lee S; Lee JE; Han PL; Lee M; Kim KK; Choi H; Lee JK
Biomaterials; 2011 Jan; 32(3):899-908. PubMed ID: 21035846
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.
Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK
J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizin suppresses HMGB1 inductions in the hippocampus and subsequent accumulation in serum of a kainic acid-induced seizure mouse model.
Luo L; Jin Y; Kim ID; Lee JK
Cell Mol Neurobiol; 2014 Oct; 34(7):987-97. PubMed ID: 24919651
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction.
Okuma Y; Liu K; Wake H; Liu R; Nishimura Y; Hui Z; Teshigawara K; Haruma J; Yamamoto Y; Yamamoto H; Date I; Takahashi HK; Mori S; Nishibori M
Neuropharmacology; 2014 Oct; 85():18-26. PubMed ID: 24859607
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats.
Ohnishi M; Katsuki H; Fukutomi C; Takahashi M; Motomura M; Fukunaga M; Matsuoka Y; Isohama Y; Izumi Y; Kume T; Inoue A; Akaike A
Neuropharmacology; 2011; 61(5-6):975-80. PubMed ID: 21752338
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizin attenuates kainic Acid-induced neuronal cell death in the mouse hippocampus.
Luo L; Jin Y; Kim ID; Lee JK
Exp Neurobiol; 2013 Jun; 22(2):107-15. PubMed ID: 23833559
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via αvβ3 Integrin Binding.
Jin YC; Lee H; Kim SW; Kim ID; Lee HK; Lee Y; Han PL; Lee JK
Mol Neurobiol; 2016 Oct; 53(8):5652-63. PubMed ID: 26482372
[TBL] [Abstract][Full Text] [Related]
17. The use of Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, in robust neuroprotection in the postischemic brain.
Kim SW; Lim CM; Lee HK; Lee JK
Anat Cell Biol; 2011 Dec; 44(4):304-13. PubMed ID: 22254159
[TBL] [Abstract][Full Text] [Related]
18. Anti-Zn
Luo L; Kim SW; Lee HK; Kim ID; Lee H; Lee JK
Cell Mol Neurobiol; 2018 Apr; 38(3):615-626. PubMed ID: 28608001
[TBL] [Abstract][Full Text] [Related]
19. CKD712, (S)-1-(α-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, inhibits the lipopolysaccharide-stimulated secretion of HMGB1 by inhibiting PI3K and classical protein kinase C.
Oh YJ; Youn JH; Min HJ; Kim DH; Lee SS; Choi IH; Shin JS
Int Immunopharmacol; 2011 Sep; 11(9):1160-5. PubMed ID: 21457762
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus.
Li YJ; Wang L; Zhang B; Gao F; Yang CM
J Pharm Pharmacol; 2019 Mar; 71(3):390-399. PubMed ID: 30417405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
